Next, this strategy was applied to solid tumors (i.e., non-hormonal prostate cancer) and showed that activation of Vγ9Vδ2 T cells in vivo was associated with the development of a pro-inflammatory(IFN-γ) responses (36). This evidence concerns the gene IFNG and prostate cancer.